June Park is the co-founder and CEO of Cenos Therapeutics, focusing on subcutaneous delivery of oligonucleotides to the brain. Previously, as CEO of siRNAgen Therapeutics, she brought SRN001 into the clinic and established the company’s US operations. June is an entrepreneur committed to advancing patient-centric and sustainable therapies. She trained as a chemical and biological engineer at MIT, where she worked at the Langer lab on RNAi delivery, and later completed her doctoral studies at the University of Cambridge as a Gates Cambridge Scholar, specializing in chemistry and stem cell biology. She has advised leading biopharmaceutical companies on commercial drug development strategies as a healthcare consultant at Putnam Associates and co-founded biotechs and ed-tech startups across US, Europe, and Africa. In her spare time, June enjoys running, cycling, and playing the violin.